Abstract:Consideration is now being given to the use of avidin (or streptavidin) and biotin for radiotherapy of tumor. Accordingly, the goal of this study was to radiolabel a mouse metallothionein-streptavidin fusion protein with 188Re and to compare its properties to those of the same fusion protein radiolabeled with 99mTc. A recombinant metallothionein-streptavidin fusion protein was radiolabeled by transchelation with 99mTc- and 188Re-glucoheptonate. Labeling efficiency, which was not optimized for either radionuclide, was approximately 60% for 99mTc and 20% for 188Re. Radiochemical purity was demonstrated by size exclusion HPLC both by nearly quantitative shifts of the 188Re label to higher molecular weight upon the addition of biotinylated antibody and by the absence of a shift with biotinsaturated 188Re-metallothionein-streptavidin. Stability of the labels in 37 degrees C serum was evaluated by comparing the HPLC radiochromatograms of serum samples both before and after the addition of biotinylated antibody. The 188Re label behaved like 99mTc in that the same peaks were evident, including one prominent peak due to labeled cysteine. Recoveries during HPLC analysis of serum samples showed that oxidation rates to perrhenate and pertechnetate were identical. However, instability to cysteine challenge was greater for 188Re; for example, the loss of label to cysteine after 24 h under one set of conditions was 41% for 188Re and 22% with 99mTc. Analysis by HPLC of liver and kidney homogenates from mice administered the labeled antibodies were qualitatively and, in large measure, quantitatively independent of label. Biodistributions at 5 h in normal mice were statistically identical between the two labels in blood and in most tissues. In conclusion, streptavidin may be radiolabeled with radiorhenium using recombinant mouse metallothionein as a bifunctional chelator, and under one set of labeling conditions at least, 188Re showed similar in vitro and in vivo behavior to that of 99mTc labeled to the same fusion protein.

Preparation and Radiolabeling of Surface-Modified Magnetic Nanoparticles with Rhenium-188 for Magnetic Targeted Radiotherapy

^188 Re Labeled MPEG-modified Superparamagnetic Nanogels：preparation and Preliminary Application in Mice

Preparation of (188re) Re-AEDP and Its Biodistribution Studies.

Biodistribution of 188Re-Aedp in Rats and Its Dependenceon Rhenium Carrier

Radiolabeling of MAG3-morpholino Oligomers with 188re at High Labeling Efficiency and Specific Radioactivity for Tumor Pretargeting.

Preparation Of186re And188re with High Specific Activity by the Szilard-Chalmers Effect

Novel candidate theranostic radiopharmaceutical based on strontium hexaferrite nanoparticles conjugated with azacrown ligand

Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives

Coordination Investigation of Rhenium with MAG3 Using LC-MS and UV Spectrometer and the Simple Radiolabelling Process

Biocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligands

A Study of the Radiosynthesis of Fac-[188Re(co)3(h2o)3]+ and Its Application in Labeling 1,2,3-Triazole Analogs Obtained by Click Chemistry

Radiolabeling, Characteristics and NanoSPECT/CT Imaging of 188Re-cetuximab in NCI-H292 Human Lung Cancer Xenografts

Surface Modification of Radionanomedicine

Anchoring Group Mediated Radiolabeling for Achieving Robust Nanoimaging Probes

Ultrasmall Fe3O4 nanoparticles self-assembly induced dual-mode T1/T2-weighted magnetic resonance imaging and enhanced tumor synergetic theranostics

Preparation of Magnetic Rattle-Type Silica Through A General and Facile Pre-Shell-Post-Core Process for Simultaneous Cancer Imaging and Therapy

Radiochemical Synthesis and Preliminary Evaluation of Anti‐bladder Cancer Monoclonal Antibody BDI‐1 Labeled with Rhenium‐188

Recombinant metallothionein-conjugated streptavidin labeled with 188Re and 99mTc

Surface design and preparation of multi-functional magnetic nanoparticles for cancer cell targeting, therapy, and imaging

Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy.

Preparation and Evaluation of a Radioisotope-Incorporated Iron Oxide Core/Au Shell Nanoplatform for Dual Modality Imaging